StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Deutsche Bank Downgrades Teva Pharma (TEVA) to Hold
November 3, 2017 5:54 AM
Deutsche Bank downgraded Teva Pharma (NYSE: TEVA) from Buy to ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Downgrades
Next Articles
Teva Pharma (TEVA) PT Lowered to $14 at Susquehanna
November 6, 2017 7:25 AM
Teva Pharma (TEVA) PT Lowered to $13 at Goldman Sachs
November 6, 2017 5:28 AM